BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36446381)

  • 1. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients.
    Khan M; Clijsters M; Choi S; Backaert W; Claerhout M; Couvreur F; Van Breda L; Bourgeois F; Speleman K; Klein S; Van Laethem J; Verstappen G; Dereli AS; Yoo SJ; Zhou H; Dan Do TN; Jochmans D; Laenen L; Debaveye Y; De Munter P; Gunst J; Jorissen M; Lagrou K; Meersseman P; Neyts J; Thal DR; Topsakal V; Vandenbriele C; Wauters J; Mombaerts P; Van Gerven L
    Neuron; 2022 Dec; 110(23):3919-3935.e6. PubMed ID: 36446381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb.
    Khan M; Yoo SJ; Clijsters M; Backaert W; Vanstapel A; Speleman K; Lietaer C; Choi S; Hether TD; Marcelis L; Nam A; Pan L; Reeves JW; Van Bulck P; Zhou H; Bourgeois M; Debaveye Y; De Munter P; Gunst J; Jorissen M; Lagrou K; Lorent N; Neyrinck A; Peetermans M; Thal DR; Vandenbriele C; Wauters J; Mombaerts P; Van Gerven L
    Cell; 2021 Nov; 184(24):5932-5949.e15. PubMed ID: 34798069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants.
    Bauer L; Rissmann M; Benavides FFW; Leijten L; van Run P; Begeman L; Veldhuis Kroeze EJB; Lendemeijer B; Smeenk H; de Vrij FMS; Kushner SA; Koopmans MPG; Rockx B; van Riel D
    Acta Neuropathol Commun; 2022 Sep; 10(1):124. PubMed ID: 36058935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2.
    Li YC; Zhang Y; Tan BH
    J Med Virol; 2021 Jul; 93(7):4247-4257. PubMed ID: 33724490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants.
    de Melo GD; Perraud V; Alvarez F; Vieites-Prado A; Kim S; Kergoat L; Coleon A; Trüeb BS; Tichit M; Piazza A; Thierry A; Hardy D; Wolff N; Munier S; Koszul R; Simon-Lorière E; Thiel V; Lecuit M; Lledo PM; Renier N; Larrous F; Bourhy H
    Nat Commun; 2023 Jul; 14(1):4485. PubMed ID: 37495586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 induces inflammation and intracranial infection through the olfactory epithelium-olfactory bulb pathway in non-human primates.
    Shimizu S; Nakayama M; Nguyen CT; Ishigaki H; Kitagawa Y; Yasui F; Yagi Y; Kusayanagi T; Kohara M; Itoh Y; Tojima I; Kouzaki H; Shimizu T
    J Neuroimmunol; 2024 Feb; 387():578288. PubMed ID: 38237527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction.
    Chen Y; Yang W; Chen F; Cui L
    J Neuroinflammation; 2022 Sep; 19(1):222. PubMed ID: 36071466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral SARS-CoV-2 Inoculation Causes Nasal Viral Infection Leading to Olfactory Bulb Infection: An Experimental Study.
    Ueha R; Ito T; Furukawa R; Kitabatake M; Ouji-Sageshima N; Ueha S; Koyama M; Uranaka T; Kondo K; Yamasoba T
    Front Cell Infect Microbiol; 2022; 12():924725. PubMed ID: 35770069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19.
    Ho CY; Salimian M; Hegert J; O'Brien J; Choi SG; Ames H; Morris M; Papadimitriou JC; Mininni J; Niehaus P; Burke A; Canbeldek L; Jacobs J; LaRocque A; Patel K; Rice K; Li L; Johnson R; LeFevre A; Blanchard T; Shaver CM; Moyer A; Drachenberg C
    JAMA Neurol; 2022 Jun; 79(6):544-553. PubMed ID: 35404378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19.
    Meinhardt J; Radke J; Dittmayer C; Franz J; Thomas C; Mothes R; Laue M; Schneider J; Brünink S; Greuel S; Lehmann M; Hassan O; Aschman T; Schumann E; Chua RL; Conrad C; Eils R; Stenzel W; Windgassen M; Rößler L; Goebel HH; Gelderblom HR; Martin H; Nitsche A; Schulz-Schaeffer WJ; Hakroush S; Winkler MS; Tampe B; Scheibe F; Körtvélyessy P; Reinhold D; Siegmund B; Kühl AA; Elezkurtaj S; Horst D; Oesterhelweg L; Tsokos M; Ingold-Heppner B; Stadelmann C; Drosten C; Corman VM; Radbruch H; Heppner FL
    Nat Neurosci; 2021 Feb; 24(2):168-175. PubMed ID: 33257876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Acute Respiratory Syndrome Coronavirus 2 Infects and Damages the Mature and Immature Olfactory Sensory Neurons of Hamsters.
    Zhang AJ; Lee AC; Chu H; Chan JF; Fan Z; Li C; Liu F; Chen Y; Yuan S; Poon VK; Chan CC; Cai JP; Wu KL; Sridhar S; Chan YS; Yuen KY
    Clin Infect Dis; 2021 Jul; 73(2):e503-e512. PubMed ID: 32667973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2: is there neuroinvasion?
    McQuaid C; Brady M; Deane R
    Fluids Barriers CNS; 2021 Jul; 18(1):32. PubMed ID: 34261487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients.
    Van Slambrouck J; Khan M; Verbeken E; Choi S; Geudens V; Vanluyten C; Feys S; Vanhulle E; Wollants E; Vermeire K; De Fays C; Aversa L; Kaes J; Van Raemdonck D; Vos R; Vanaudenaerde B; De Hertogh G; Wauters E; Wauters J; Ceulemans LJ; Mombaerts P
    EBioMedicine; 2023 Jun; 92():104608. PubMed ID: 37224768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory gyrus intracerebral hemorrhage in a patient with COVID-19 infection.
    Thu SS; Matin N; Levine SR
    J Clin Neurosci; 2020 Sep; 79():275-276. PubMed ID: 33070912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-viral effects of COVID-19 in the olfactory system and their implications.
    Xydakis MS; Albers MW; Holbrook EH; Lyon DM; Shih RY; Frasnelli JA; Pagenstecher A; Kupke A; Enquist LW; Perlman S
    Lancet Neurol; 2021 Sep; 20(9):753-761. PubMed ID: 34339626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
    Bauer L; van Riel D
    mBio; 2023 Feb; 14(1):e0292022. PubMed ID: 36651750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Shift in SARS-CoV-2 Omicron Variant's Entry Pathway Might Explain Different Clinical Outcomes.
    Machado-Curbelo C; Gutiérrez-Gil J; González-Quevedo A
    MEDICC Rev; 2022 Oct; 24(3-4):68-71. PubMed ID: 36417338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?
    Liang F; Wang Y
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection.
    Butowt R; Bilinska K
    ACS Chem Neurosci; 2020 May; 11(9):1200-1203. PubMed ID: 32283006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.